InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (8 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
8
T+90 hit rate
25%
T+90 mean return
-8.1%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Atlas Venture Fund XI, L.P.. Officer active across 6 companies, notably Day One Biopharmaceuticals, Inc.. In total, 23 disclosures have been recorded. Split: 2 buys · 8 sells. Total volume traded: €13.4m. Activity tracked since 13 July 2021. The latest transaction was filed on 1 November 2024 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations23 total
2,886,293 sharesCommon StockSEC:0000950170-25-017030:0
515,688 shares0Common StockSEC:0001415889-24-026125:0
136,312 shares@ US$23.5929.8% of flowCommon StockSEC:0001415889-24-005777:0
149,337 shares@ US$22.4431.0% of flowCommon StockSEC:0001415889-24-005124:0
175,793 shares@ US$23.8839.2% of flowCommon StockSEC:0001415889-24-004467:0
733 shares@ US$0.6411.7% of flowCommon StockSEC:0001209191-24-003031:0
1,566 shares@ US$0.8733.4% of flowCommon StockSEC:0001209191-24-001655:0
569 shares@ US$0.8712.1% of flowCommon StockSEC:0001209191-24-001655:1
1,540 shares@ US$0.8331.3% of flowCommon StockSEC:0001209191-24-001655:2
560 shares@ US$0.8311.4% of flowCommon StockSEC:0001209191-24-001655:3
600,854 shares0Common StockSEC:0001209191-22-061242:0
600,854 shares0Common StockSEC:0001209191-22-050928:0
6,472,374 sharesCommon StockSEC:0001209191-22-050535:0
125,000 shares@ US$16.0050.0% of flowCommon StockSEC:0001209191-21-069644
Ideal exit: 25 Dec 2021 (T+270)
125,000 shares@ US$16.0050.0% of flowCommon StockSEC:0001209191-21-069644:0
Ideal exit: 25 Dec 2021 (T+270)
801,138 shares0Common StockSEC:0001209191-21-067018:0
801,138 shares0Common StockSEC:0001209191-21-067018
1,372,998 sharesCommon StockSEC:0001104659-21-130026:0
1,372,998 sharesCommon StockSEC:0001104659-21-130026
814,013 shares0Common StockSEC:0001209191-21-046784
814,013 shares0Common StockSEC:0001209191-21-046784:0
7,761,380 sharesCommon StockSEC:0001209191-21-037402
7,761,380 sharesCommon StockSEC:0001209191-21-037402:0
23 of 23 declarations
About Atlas Venture Fund XI, L.P.
Atlas Venture Fund XI, L.P. serves as a director and insider for several companies, including Day One Biopharmaceuticals, Inc., Dyne Therapeutics, Inc., Xilio Therapeutics, Inc., and Ikena Oncology, Inc.
